Blog

Jul 16, 2016

Pancreatic cancer ‘breakthrough’ hailed

Posted by in categories: biotech/medical, innovation

Researchers in the U.K. have made what is described as a “breakthrough reclassification” of pancreatic cancer, which offers new opportunities to treat the often-fatal disease.

A study co-led by professor Andrew Biankin and colleagues at the University of Glasgow’s Institute of Cancer Sciences has found four “key subtypes” of the cancer, with each possessing “their own distinct clinical characteristics and differential survival outcomes,” according to a statement released on Thursday.

The researchers’ paper was published in the journal Nature, and named the subtypes as:

Read more

Comments are closed.